Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NXLIW

Nexalin Technologies (NXLIW)

Nexalin Technologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NXLIW
DateTimeSourceHeadlineSymbolCompany
01/14/20257:30AMGlobeNewswire Inc.Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025NASDAQ:NXLIWNexalin Technologies Inc
01/10/20253:35PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NXLIWNexalin Technologies Inc
12/23/20249:00AMGlobeNewswire Inc.Nexalin Technology Completes Phase 1of its Innovative Virtual ClinicNASDAQ:NXLIWNexalin Technologies Inc
12/20/202411:35AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NXLIWNexalin Technologies Inc
11/26/20249:00AMGlobeNewswire Inc.New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation MarketNASDAQ:NXLIWNexalin Technologies Inc
11/11/20247:00AMGlobeNewswire Inc.Nexalin Technology CEO Provides Letter to ShareholdersNASDAQ:NXLIWNexalin Technologies Inc
11/08/20243:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXLIWNexalin Technologies Inc
11/01/20241:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
11/01/20241:00PMGlobeNewswire Inc.Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5thNASDAQ:NXLIWNexalin Technologies Inc
11/01/20249:34AMGlobeNewswire Inc.Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NXLIWNexalin Technologies Inc
10/30/20249:55AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
10/28/20247:30AMGlobeNewswire Inc.Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's DiseaseNASDAQ:NXLIWNexalin Technologies Inc
10/22/20241:15PMGlobeNewswire Inc.Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VANASDAQ:NXLIWNexalin Technologies Inc
10/17/20247:30AMGlobeNewswire Inc.New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s PatientsNASDAQ:NXLIWNexalin Technologies Inc
10/14/20247:30AMGlobeNewswire Inc.Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory AffairsNASDAQ:NXLIWNexalin Technologies Inc
10/02/20241:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
09/19/20243:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
09/05/20248:00AMGlobeNewswire Inc.Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid TreatmentNASDAQ:NXLIWNexalin Technologies Inc
07/18/20247:30AMGlobeNewswire Inc.Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use RecoveryNASDAQ:NXLIWNexalin Technologies Inc
07/01/20241:45PMGlobeNewswire Inc.Nexalin Technology Announces Closing of $5.2 Million Public OfferingNASDAQ:NXLIWNexalin Technologies Inc
06/27/20248:15PMGlobeNewswire Inc.Nexalin Technology Announces Pricing of $5.2 Million Public OfferingNASDAQ:NXLIWNexalin Technologies Inc
06/26/20248:00AMGlobeNewswire Inc.Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific JournalNASDAQ:NXLIWNexalin Technologies Inc
06/20/20247:30AMGlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and DementiaNASDAQ:NXLIWNexalin Technologies Inc
06/18/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
06/14/20248:53AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NXLIWNexalin Technologies Inc
06/13/20242:00PMGlobeNewswire Inc.Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)NASDAQ:NXLIWNexalin Technologies Inc
06/12/202412:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
06/04/20247:30AMGlobeNewswire Inc.Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6thNASDAQ:NXLIWNexalin Technologies Inc
06/03/20247:30AMGlobeNewswire Inc.FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset DeviceNASDAQ:NXLIWNexalin Technologies Inc
05/23/20244:17PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NXLIWNexalin Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:NXLIW

Your Recent History

Delayed Upgrade Clock